Literature DB >> 7862908

Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?

G Tanda1, E Carboni, R Frau, G Di Chiara.   

Abstract

Drugs differing in their primary mechanism of action but having in common the ability to act as antidepressants such as fluoxetine (10 mg/kg SC), clomipramine (10 mg/kg IP), imipramine (10 mg/kg IP), desipramine (10 mg/kg IP) and (+/-) 8-OHDPAT (0.03 mg/kg SC) increase extracellular concentrations of dopamine in the rat prefrontal cortex but not in the medial nucleus accumbens. Buspirone (1 mg/kg SC) increased dopamine both in the prefrontal cortex and in the nucleus accumbens. Extracellular 5HT was increased by fluoxetine, clomipramine and imipramine but not by desipramine while 8-OHDPAT and buspirone decreased it. These results raise the possibility that the property of stimulating dopamine transmission in the prefrontal cortex has a role in the antidepressant properties of these drugs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862908     DOI: 10.1007/bf02244785

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Presynaptic dopamine release is enhanced by 5-HT3 receptor activation in medial prefrontal cortex of freely moving rats.

Authors:  J Chen; W Paredes; H M Van Praag; J H Lowinson; E L Gardner
Journal:  Synapse       Date:  1992-03       Impact factor: 2.562

2.  Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals.

Authors:  E Carboni; G L Tanda; R Frau; G Di Chiara
Journal:  J Neurochem       Date:  1990-09       Impact factor: 5.372

Review 3.  Use of specific serotonin uptake inhibitors as antidepressants.

Authors:  L Lemberger; R W Fuller; R L Zerbe
Journal:  Clin Neuropharmacol       Date:  1985       Impact factor: 1.592

4.  On the preferential release of dopamine in the nucleus accumbens by amphetamine: further evidence obtained by vertically implanted concentric dialysis probes.

Authors:  G Di Chiara; G Tanda; R Frau; E Carboni
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  A functional anatomical study of unipolar depression.

Authors:  W C Drevets; T O Videen; J L Price; S H Preskorn; S T Carmichael; M E Raichle
Journal:  J Neurosci       Date:  1992-09       Impact factor: 6.167

6.  Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites.

Authors:  A Imperato; G Di Chiara
Journal:  J Neurosci       Date:  1984-04       Impact factor: 6.167

Review 7.  Dopamine and depression: a review of recent evidence. I. Empirical studies.

Authors:  P Willner
Journal:  Brain Res       Date:  1983-12       Impact factor: 3.252

Review 8.  Dopamine and depression: a review of recent evidence. III. The effects of antidepressant treatments.

Authors:  P Willner
Journal:  Brain Res       Date:  1983-12       Impact factor: 3.252

9.  Serotonin release estimated by transcortical dialysis in freely-moving rats.

Authors:  E Carboni; G Di Chiara
Journal:  Neuroscience       Date:  1989       Impact factor: 3.590

10.  Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.

Authors:  M S Buchsbaum; J Wu; L E DeLisi; H Holcomb; R Kessler; J Johnson; A C King; E Hazlett; K Langston; R M Post
Journal:  J Affect Disord       Date:  1986 Mar-Apr       Impact factor: 4.839

View more
  63 in total

1.  Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.

Authors:  M Hajós; E Hajós-Korcsok; T Sharp
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

2.  The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions.

Authors:  Eleni T Tzavara; Richard J Davis; Kenneth W Perry; Xia Li; Craig Salhoff; Frank P Bymaster; Jeffrey M Witkin; George G Nomikos
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

Review 3.  Dopamine tunes prefrontal outputs to orchestrate aversive processing.

Authors:  Caitlin M Vander Weele; Cody A Siciliano; Kay M Tye
Journal:  Brain Res       Date:  2018-12-01       Impact factor: 3.252

4.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

5.  Involvement of 5-HT(3) receptors in the nucleus accumbens in the potentiation of cocaine-induced behaviours in the rat.

Authors:  S Herges; D A Taylor
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 6.  A neurochemical yin and yang: does serotonin activate and norepinephrine deactivate the prefrontal cortex?

Authors:  Paul J Fitzgerald
Journal:  Psychopharmacology (Berl)       Date:  2010-04-13       Impact factor: 4.530

7.  Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain.

Authors:  T Kobayashi; K Matsuno; M Murai; S Mita
Journal:  Neurochem Res       Date:  1997-09       Impact factor: 3.996

8.  Brain monoamines and antidepressant-like responses in MRL/MpJ versus C57BL/6J mice.

Authors:  Darrick T Balu; Jill R Turner; Bethany R Brookshire; Tiffany E Hill-Smith; Julie A Blendy; Irwin Lucki
Journal:  Neuropharmacology       Date:  2012-12-06       Impact factor: 5.250

9.  The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.

Authors:  G G Nomikos; L Arborelius; B B Höök; U Hacksell; T H Svensson
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

10.  A new strategy for antidepressant prescription.

Authors:  Francis Lavergne; Thérèse M Jay
Journal:  Front Neurosci       Date:  2010-11-19       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.